Spectrum Pharmaceuticals (SPPI) Raises Buyback Plan to $100M

Spectrum Pharmaceuticals (Nasdaq: SPPI) announced that the Company’s Board of Directors has approved an increase in its stock repurchase program authorizing the repurchase of up to a total of $100 million of the Company's common stock. The Company was previously authorized to repurchase up to $25 million of its stock.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• KB Home (KBH) Announces $1B Share Buyback, Raises Dividend
• PPG Industries (PPG) Declares $0.65 Quarterly Dividend; 1.9% Yield
• Commerce Bancshares (CBSH) Approves Stock Repurchase Program